As the JR Group toasts its 30th anniversary, a celebratory dinner in Glasgow will channel the firm's success into a powerful ...

In July, President Donald Trump signed the One Big Beautiful Bill Act into law, bringing cuts of around $1 trillion to ...

Anavex Life Sciences' Phase 2B/3 trial failed to achieve statistical significance on both primary endpoints. Read why I ...

As the JR Group toasts its 30th anniversary, a celebratory dinner in Glasgow will channel the firm's success into a powerful effort to ...

Unravel Biosciences, Inc., ("Unravel"), a clinical-stage therapeutics company established to advance drugs for complex diseases through its Predictable Medicine™ platform, today announced the approval ...

Vesting of each stock option is subject to suchemployee's continued service to Taysha on each vesting date. About Taysha Gene Therapies Taysha Gene Therapies (Nasdaq: TSHA) is a clinical-stage ...

ACADIA Pharmaceuticals generates revenue primarily through the commercialization of NUPLAZID for Parkinson's disease ...

Acadia Pharmaceuticals Inc. is rated a Buy for its steady NUPLAZID/DAYBUE franchises & pipeline-driven upside potential. Read more on ACAD stock here.

An offshore trial has found a link between kidney malfunction and Alzheimer's, while a local biotech legend takes a different ...

Some of the most transformative breakthroughs in science history arrived wrapped in obscurity. Dr. Rosalind Franklin captured Photo 51—the X-ray crystallography image that revealed DNA’s double ...

As the U.S. faces a shortage of special education workers, H.E.A.R.T.S Connection is providing support to the families of ...

A single mother of six children on Oahu is facing a medical emergency, a recent diagnosis, and a difficult year, but the community is coming together to help her and her family through the Laulima ...